ClinicalTrials.Veeva

Menu

Silver Nanoparticles in Multidrug Resistant Bacteria

A

Assiut University

Status

Completed

Conditions

Multidrug Resistent Bacteria

Treatments

Other: silver nanoparticles

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)

Enrollment

150 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intensive care patients

Exclusion criteria

  • none

Trial design

150 participants in 2 patient groups

Methicillin resistant staphylococcus aureus
Treatment:
Other: silver nanoparticles
vancomycin resistent staphylococcus aureus
Treatment:
Other: silver nanoparticles

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems